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Abstract 
Background: Over recent decades, Brazilian mortality registration has undergone increasing improvement in terms 
of completeness and quality in cause of death reporting. These improvements, however, complicate the description 
of mortality trends over this period. We aim to characterize the trend in diabetes mortality in Brazil and its five regions 
in adults (30–69 years), from 1996 to 2011 after corrections for underreporting of deaths and redistribution of ill-
defined causes and “garbage codes”.
Methods: Starting with official data from the Brazilian Mortality Information System (SIM) for adults aged 30–69 in 
the period 1996 to 2011 for diabetes (ICD-10 codes E10-14), we redistributed garbage codes using methods based on 
the Global Burden of Disease Study (2010), redistributed ill-defined causes based on recent Brazilian investigations of 
similar cases and corrected for underreporting using official estimates of deaths.
Results: With these corrections, age-standardized mortality fell approximately 1.1 %/year for men and 2.2 %/year for 
women from 1996 to 2011. The rate of decline first accelerated and then decelerated, reaching stable rates in men 
and minimal declines in women from 2005 onward. Regional inequalities decreased during the period in both relative 
and absolute terms.
Conclusion: Mortality due to diabetes declined in Brazil from 1996 to 2011, minimally in men and considerably in 
women. The lesser declines in recent years may reflect the increasing prevalence of diabetes, and suggest that current 
efforts to prevent diabetes and minimize the impact of its complications need to be reinforced to ensure that declines 
will continue.
© 2015 Schmidt et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Diabetes, a state of hyperglycemia defined by greater risk 
of microvascular damage (retinopathy, nephropathy and 
neuropathy), is increasingly recognized as an important 
public health problem. Diabetes reduces life expectancy, 
augments morbidity due to microvascular and macrovas-
cular complications (ischemic heart disease, stroke and 
peripheral vascular disease), increases premature mortal-
ity, and diminishes the quality of life [1].
It has been estimated that 387 million people had dia-
betes in 2013 and that 592 million will have the disease 
in 2035. Approximately half of those with diabetes are 
under 60 years of age, and 77 % of those with diabetes live 
in low- and middle-income countries. This scenario is of 
great concern given that Type 2 diabetes, the most com-
mon form of the disease, is likely to continue to rise as 
a consequence of population ageing and urbanization, as 
well as of the current obesity epidemic, resulting in very 
high direct and indirect costs to individuals and to soci-
ety [2]. Although not fully understood, the epidemic of 
diabetes may result not only from increased incidence, 
but also from improved survival. Improved survival has 
been demonstrated in some developing countries [3].
The Global Burden of Disease (GBD) Study reported 
a 9.0 % increase in standardized mortality from diabetes 
between 1990 and 2013, with diabetes progressing from 
the 26th to the 17th leading cause of years of life lost 
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globally. In 2013 diabetes was the 7th cause of years of 
life lost in Brazil [4].
Scant data exist with respect to trends in diabetes mor-
tality for Brazil, a high-middle income country in which 
known diabetes prevalence is 6.2  % [5], and in which 
approximately 50 % of diabetes is estimated to be undi-
agnosed [6]. Increases in diabetes mortality have been 
reported in recent decades [7–9], possibly due in part 
to a greater diabetes prevalence and better recognition 
of diabetes as a cause of death. These analyses, however, 
have not incorporated corrections for problems in mor-
tality reporting.
Analyses of trends in mortality in Brazil remain a chal-
lenge. Although the Brazilian Mortality Information 
System (SIM) is universal and consolidated, coverage of 
deaths and quality of information on causes of death are 
unequal across space and time, with sub-enumeration of 
deaths and a high proportion of ill-defined causes among 
registered deaths in some areas [10, 11]. Thus, analyses 
of trends require the accounting of these factors to avoid 
bias in comparisons across regions and over time.
Analyses incorporating these corrections have found 
a sharp decrease in the age-standardized mortality for 
non-communicable diseases in recent decades [12], 
mainly due to falls in cardiovascular and chronic res-
piratory diseases. This could result in improved survival 
among diabetic individuals, and therefore contribute to 
the increased diabetes prevalence in Brazil. However, 
over the same period, declines in diabetes mortality were 
modest [13].
This study aims to characterize further the trend in 
diabetes mortality in Brazil and its five regions in adults 
(30–69 years), from 1996 to 2011, using the method for 
correction of under-registration of deaths currently rec-
ommended by the Ministry of Health together with a 
new method of reallocating ill-defined causes, redistrib-
uting not just those formally declared as ill-defined but 
also those initially reported within the so-called “garbage 
codes”.
Methods
We used the Brazilian Mortality Information System 
(SIM) for the period 1996 to 2011 to obtain the reported 
numbers of deaths of adults aged 30–69  years from the 
public website of the Ministry of Health [14]. Procedures 
used were similar to those employed by the GBD2010 
[15], unless indicated. Deaths whose underlying cause 
was diabetes were selected using all ICD-10 diabetes 
codes (E10.0–E14.9). After reallocating the small frac-
tion of deaths with missing information for sex and age of 
death, data were corrected following three steps.
First, we considered as “garbage codes” all deaths from 
nonspecific causes within ICD-10 chapters of defined 
causes (i.e., all chapters except Chapter XVIII). We defined 
the fraction of each specific ICD-10 garbage code to be 
redistributed to “target” diabetes codes, separately by sex, 
age and region, adapted from the list of garbage codes of 
GBD-2010, adding deaths redistributed from these garbage 
codes to those directly reported as due to diabetes [15, 16].
Second, we redistributed codes from ill-defined causes 
of deaths (Chapter XVIII of ICD-10). We did this sepa-
rately by sex, five-year age group and region, in the 
proportions similar to those found for diabetes dur-
ing routine investigations carried out by state and local 
health departments in the country since 2006 [17].These 
proportions, here called IDC redistribution coefficients 
(RD-IDC), were defined for each year, region and sex. We 
used data from the same year’s investigation for redistri-
bution in the years between 2006 and 2011, and the mean 
RD-IDCs over 2006–2011 for the period 1996–2005, 
which preceded this investigation of ill-defined causes.
Third, we corrected the numbers produced in the sec-
ond step for underreporting of deaths for the years 1996 
to 2011, by applying the inverse of the ratio of reported/
estimated deaths by the Ministry of Health [18]. This step 
produced the corrected number of total deaths in each 
sex and five-year age group, in each geographical region.
We next produced mortality rates by applying popu-
lation denominators obtained from the 1991, 2000 and 
2010 Brazilian censuses from IBGE to these numbers of 
deaths. Intercensus population estimates by age and sex 
were obtained by logarithmic interpolation of the census 
population. We then performed direct standardization 
to the 2010 Brazilian population to produce yearly age 
standardized death rates (/100,000 population) overall 
and by region and sex.
We investigated time trends in these standardized mor-
tality rates, from 1996 to 2011, with a linear regression 
model which assumes a constant (linear) trend over the 
series, to test the hypothesis of a positive or a negative 
trend (slope different from zero). To adjust for the pres-
ence of first order autocorrelation, the residuals of the 
regression were modeled as a first order autoregressive 
process [19, 20]. It was then possible to test if the mor-
tality series presents a significant increasing or decreas-
ing trend. Finally, to explore nuances in trends, we used a 
state space model [21], which does not assume trends to 
be fixed but rather variable over time. 
The Ethics in Research Committee of the Hospital de 
Clínicas de Porto Alegre (No. 100056) has approved the 
use of information from surveillance databases for the 
investigation of chronic diseases by the Collaborative 
Center for the Surveillance of Diabetes, Cardiovascular 
and Other Chronic Diseases of the Federal University of 
Rio Grande do Sul. Given that databases employed had 
no personal identifiers, no patient consent was necessary.
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Results
A total of 294,203 deaths due to diabetes were officially 
reported between 1996 and 2011 (Table  1). The type of 
diabetes was unspecified for the vast majority (91.2 %) of 
deaths. Acute complications (ICD code final digit .0 or .1) 
were responsible for 10.6  % of reported deaths, renal 
complications 19.1  %, peripheral circulatory complica-
tions 6.1  %, other complications 12.4  %, while deaths 
“without complications” corresponded to 51.9  % of the 
total deaths.
We present on Table 2 the proportions of each group of 
“garbage codes” redistributed to diabetes. Non-specified 
causes of renal failure were the most likely to be so redis-
tributed: 57.3 % of deaths due to this cause (2979 deaths 
in 1996 and 2911 in 2011) were redistributed to diabetes.
Table 3 demonstrates the fraction of ill-defined (chap-
ter XVIII-ICD10) codes that were then redistributed 
to diabetes. In all, 55,195 deaths officially coded as ill-
defined were redistributed to diabetes. The percent that 
was redistributed varied considerably by region and sex, 
being less in the Center-West region and women having 
approximately double the percent redistributed of men.
As a result of correction for underreporting of deaths, 
a total of 41,472 deaths were then added, the net addition 
being most pronounced for the North and the Northeast 
regions.
Table  4 shows the effect of all these corrections on 
the total number of deaths and on the age-standardized 
mortality rates for 1996 and 2011, the first and last years 
analyzed. In 1996, the corrections resulted in 11,616 
additional deaths due to diabetes, an increment of 85 % in 
total deaths. With improvements in mortality reporting, 
less deaths were redistributed by 2011, 7334, represent-
ing an increment of 30.7 % in total deaths due to diabetes. 
Correction exerted a greater effect on rates in the North 
and Northeast, regions with the highest diabetes mortal-
ity rates in 2011 for both men and women.
Figure  1 shows the trend in mortality due to diabetes 
for Brazil, from 1996 to 2011. Comparing the uncor-
rected (dashed lines) with the corrected (solid lines) rates, 
we observe that a picture of low and if anything rising 
rates is transformed into one of higher rates in decline, 
especially for women. The decline is approximately 
twice as large in women (1.01 deaths/100,000/year, 
2.2  %/year, P  <  0.001; red line) as men (on average .49 
deaths/100,000/year, 1.1  %/year, P  <  0.001; blue line), 
leading to a 30.5 % drop for women, and a 14.3 % drop for 
men, over the 15 year period.
Figure 2 shows this decline, separately in each of Bra-
zil’s five regions. Declines were largest in both relative 
and absolute terms in the Northeast and Southeast. In 
the Northeast, rates declined 1.9 %/year and 38.6 % over-
all for women and 0.74 %/year and 17.7 % overall for men.
Figure  3 show the evolution of the trend over time 
according to the state-space model, which estimates 
the change in rate in each year compared to the previ-
ous year. The trend over time is one of annual declines 
of varying size since the beginning of the series. In the 
period from 1998 to 2006, the decrease from 1  year to 
the next was more accentuated for women. Since 2007, 
little change in rate has been observed for both men and 
women.
Table 1 Number of deaths due to diabetes by specific ICD-10 causes of death
Mortality Information System (SIM), Brazil, 1996–2011
DM1 type 1 diabetes, DM2 type 2 diabetes, MR DM malnutrition-related diabetes
ICD Code number E10 E11 E12 E13 E14 Total
DM1 DM2 MR DM Other Unspecified
ICD Code final digit N N N N N N %
.0 With coma 1008 730 28 48 11,925 13,739 4.7
.1 With ketoacidosis 1134 503 12 71 15,500 17,220 5.9
.2 With renal complications 1397 3350 35 41 51,261 56,084 19.1
.3 With ophthalmic complications 17 17 2 2 108 146 0.0
.4 With neurological complications 91 79 3 2 630 805 0.3
.5 With peripheral circulatory complications 519 988 10 37 16,368 17,922 6.1
.6 With other specified complications 159 241 524 19 3346 4289 1.5
.7 With multiple complications 1369 944 132 60 8180 10,685 3.6
.8 With unspecified complications 1073 1014 22 150 18,438 20,697 7.0
.9 Without complications 2823 7084 35 88 142,586 152,616 51.9
Total N 9590 14,950 803 518 268,342 294,203 100.0
% 3.3 5.1 0.3 0.2 91.2 100.0
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Discussion
Our findings demonstrate a decline in standardized dia-
betes mortality (ICD-10 codes E10-E14) of approximately 
1  %/year for men and 2.2  %/year for women from 1996 
to 2011 in Brazil. This decrease in mortality due to dia-
betes became apparent only after corrections for ill-
defined causes of death and under registration. The rate 
of decline first accelerated and then decelerated over 
the period. The trend was observed in all regions, and 
attenuated regional inequalities in diabetes mortality in 
relative and absolute terms.
These findings highlight the need to incorporate the 
progressive improvements in the mortality system in 
Brazil over the last two decades when describing trends 
during the period. At the end of our series, in 2011, cor-
rection for remaining mortality system deficiencies 
resulted in an increment of approximately 30 % to deaths 
reported as being due to diabetes. In 1996, the incre-
ment was approximately 85 %. Without these corrections 
to account for improvements in the quality of mortality 
reporting, the decline was hidden by the increasing cov-
erage and the increasingly correct attribution of diabe-
tes as the underlying cause in the mortality registry. The 
inclusion of these corrections, as seen in Fig. 1, changed 
the interpretation of trends over the period from one 
of stability in women and a slight increase in men, to 
declines in age-adjusted mortality in both sexes.
Earlier studies of diabetes mortality in Brazil, focused 
on state capitals to minimize the limitations of the mor-
tality information system for Brazil as a whole and cov-
ering the initial years of our series, have found varying 
declines in mortality in some capitals in the Northeast 
and Southeast [8, 9].
Analyses of mortality trends in Brazil taking into 
account the variability across space and time of the insuf-
ficiencies of the system has received great attention over 
the past 5  years. Applying corrections for under report-
ing and ill-defined causes of death to mortality due to the 
four main non communicable diseases in Brazil revealed 
a sharp decrease for cardiovascular and chronic respira-
tory diseases and a modest decrease for diabetes and can-
cer [12]. Progressive refinements in the methods for these 
corrections also revealed modest declines in standardized 
mortality due to diabetes: 0.89 %/year from 2000 to 2009 
[22]; 1.7 %/year from 2000 to 2011 [13]; and 1.64 %/year 
in women and 0.40 %/year in men from 2000 to 2011 [23].
Our findings, more detailed and focused in diabetes, 
were based on more updated correction algorithms, 
including redistribution of deaths initially coded in gar-
bage codes. The trend we found, producing a U-shaped 
curve of rate change, particularly among women, with a 
deceleration from 2005 onward, not previously reported, 
deserves reflection.
These rates, and their change over time, summarize the 
effects of competing forces within a very complex epide-
miologic picture. Over this period, the prevalence of diabe-
tes has increased considerably. Data are sparse with respect 
to the prevalence of diabetes in the 1990s in Brazil, almost 
always being based on self-report. The self-reported preva-
lence, estimated from a national survey in 1998 of those 20 
or older, was 3.3 % [24]. It increased almost 100 %, to 6.2 % in 
the Brazilian National Health Survey (Pesquisa Nacional de 
Table 3 Percent of R codes* redistributed to diabetes
Brazil, 2006–2011
* ICD-10 Chapter XVIII: Symptoms, signs and abnormal clinical and laboratory 
findings, not elsewhere classified
Year Region Redistributed to diabetes
Men (%) Women (%)
1996–2005 North 4.87 8.81
1996–2005 Northeast 5.97 10.54
1996–2005 Southeast 6.61 9.73
1996–2005 South 4.60 8.70
1996–2005 Center-West 1.72 2.38
2006 North 4.57 10.00
2006 Northeast 5.11 7.04
2006 Southeast 7.82 10.83
2006 South 2.79 5.26
2006 Center-West 6.08 8.89
2007 North 3.43 7.59
2007 Northeast 5.95 11.63
2007 Southeast 7.74 11.35
2007 South 3.24 7.75
2007 Center-West 0.29 0.92
2008 North 4.43 4.00
2008 Northeast 6.89 11.44
2008 Southeast 7.23 10.47
2008 South 2.46 7.74
2008 Center-West 1.28 2.78
2009 North 5.33 8.67
2009 Northeast 6.36 12.98
2009 Southeast 7.56 10.12
2009 South 5.81 9.38
2009 Center-West 1.06 0.00
2010 North 5.52 9.63
2010 Northeast 5.32 9.76
2010 Southeast 5.81 9.13
2010 South 6.16 8.83
2010 Center-West 1.76 1.34
2011 North 5.31 11.91
2011 Northeast 6.42 11.10
2011 Southeast 4.89 7.72
2011 South 4.63 9.79
2011 Center-West 3.27 5.63
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Saúde, or PNS) of those 18 or older, conducted in 2013 [5]. 
The increase in prevalence may have resulted from greater 
diagnosis as well as from greater incidence of diabetes.
Thus, a considerably larger fraction of the population 
was at risk to die of diabetes and to have this reported as 
a cause of death in more recent years. As such, improving 
mortality among those with diabetes competes with the 
growing prevalence of diabetes to define the mortal-
ity trend. Further declines in diabetes mortality may be 
difficult to achieve if the growing prevalence of diabetes 
persists. The fact that the decline was greater in women 
may, in part, reflect that the prevalence of diabetes is not 
Table 4 Effect of  correction for  underreporting of  deaths and  ill-defined causes of  death on  the number of  deaths 
and age-adjusted mortality rates (/100,000)* due to diabetes in adults, by region and sex
SIM, Brazil, 1996 and 2011
* Mortality rates standardized to the age structure of the population of Brazil in 2010
Region 1996 2011
Before correction After correction Change Before correction After correction Change
n Rate n Rate % n Rate n Rate %
Men
 North 202 14.1 639 44.1 212.8 820 31.5 1248 47.5 50.8
 Northeast 1187 18.3 3844 59 222.4 3599 35.3 4953 48.6 37.7
 Southeast 3634 30.6 5521 46.2 51.0 5218 28 6870 36.8 31.4
 South 954 22.8 1358 32.4 42.1 1787 26.7 2203 33 23.6
 Center-West 305 19.2 527 33.1 72.4 744 25.9 975 33.8 30.5
 Brazil 6282 24.6 11889 46.2 87.8 12168 29.7 16249 39.6 33.3
Women
 North 205 15.8 661 49.3 212.0 784 31.2 1146 45.2 44.9
 Northeast 1600 21.6 5139 69.3 220.8 3787 32.3 4980 42.6 31.9
 Southeast 4023 30.1 5449 40.6 34.9 4802 22.3 6010 27.9 25.1
 South 1059 23 1444 31.2 35.7 1625 21.7 1949 26.1 20.3
 Center-West 319 21.2 522 34.1 60.8 749 24.9 915 30.4 22.1
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on
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on Women Before Correc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Fig. 1 Trends in age-standardized diabetes mortality rates (/100,000) before and after correction for men (blue) and women (red). SIM, Brazil, 
1996–2011. Rates are standardized to the 2010 age distribution of the Brazilian population
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increasing as quickly in women during this period. Com-
paring results from nationally representative household 
surveys demonstrate that the annual rate of increase in 
the prevalence of self-reported diabetes was 9 % in men 
while only 6.3 % in women from 1998 to 2013 [5, 25].
The regional differences we observed in trends, par-
ticularly in the Northeast where absolute declines in 
women were double the national average and in men 
approximately 60  % greater, suggest that actions by the 
SUS, the Brazilian National Health System, to reduce 
inequities are being effective in terms of the care of those 
with diabetes. It is worth nothing that Alves et  al., who 
investigated trends by state instead of region, found het-
erogeneity across states within the same region [23].
Possible reasons for the declines in mortality due to 
diabetes should be considered. Over this period the 
SUS expanded its coverage greatly, particularly in terms 
of primary care. In the 1990´s a National Diabetes Plan 
worked especially to guarantee greater access to insulin. 
In 2001, the national Plan to Reorganize Care of Hyper-
tension and Diabetes Mellitus was instituted, focused on 
redirecting the care of diabetes from the hospital to pri-
mary care [26]. The National Program of Pharmaceuti-
cal Provision for Hypertension and Diabetes was created 
in 2002. This Program, along with subsequent laws and 
regulations, has resulted in a progressively larger distri-
bution of medicines and medical supplies, free of charge, 
to those with diabetes [27]. Mortality from the acute 
causes of diabetes has fallen 71 % from the beginning of 
the 1990s to 2010 [28]. As these acute causes of death are 
those most sensitive to access and availability of insu-
lin and other medications, they most likely result from 
the above-mentioned actions as well as the increasing 
organization of emergency care facilities, transport, and 
hotline support systems [29]. Undoubtedly, the increased 
standard of living, the rise of the Brazilian middle class, 
decreasing poverty and efforts to eradicate severe pov-
erty such as the cash transfer program bolsa família may 
have also played a difficult-to-estimate but important 
role in the decline [30]. Unfortunately, given that diabe-
tes type was “unspecified” for 91 % of deaths, the data do 
not permit the description of declines for specific types 
of diabetes.
Additionally, and also in part due to the above men-
tioned reasons, mortality from chronic diseases in gen-
eral and cardiovascular diseases in particular, the major 
causes of diabetes deaths, has fallen considerably [12]. 
Declining rates of smoking, a major risk factor for com-
plications of diabetes, also fell considerably over this 
period. Improved care of diabetes has been postulated 
to explain documented increased survival among those 
with diabetes in various high income countries, including 
Sweden, the UK and Taiwan [3]. In the US, findings from 
the National Health Interview Survey (1997–1998, 1999–
2000, 2001–2002, and 2003–2004 for adults aged 18 years 
and older show that among diabetic adults, the CVD 
death rate declined by 40 % (95 % CI 23–54) and all-cause 
mortality declined by 23 % (10–35) between the earliest 
and latest samples. The excess CVD mortality rate asso-
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Fig. 2 Trends in diabetes mortality in Brazil, by region, 1996–2011. 
Panel  a men, Panel  b women. Rates are standardized to the 2010 age 






























































Fig. 3 Annual change in diabetes mortality, after correction of the 
data, according to the state-space model. Brazil, 1996–2011
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rates of nondiabetic adults) decreased by 60 % (from 5.8 
to 2.3 CVD deaths per 1000) while the excess all-cause 
mortality rate declined by 44 % (from 10.8 to 6.1 deaths 
per 1000) [31].
Thus, our findings of decreasing mortality due to dia-
betes are likely to result from improved care to diabetes 
in Brazil over the last two decades. Yet, the deceleration 
observed more recently may indicate that further declines 
will only occur with further strengthening in the organi-
zation of care of those with diabetes. Moreover, primary 
prevention efforts, including population-oriented pub-
lic health actions such as food and agricultural policies 
aimed at making healthy choices easier, are much needed 
to stem the increase in diabetes incidence.
Strengths and limitations of our investigation merit 
comment. Among the strengths is the use of method-
ologies to correct for deficiencies in the Brazilian sys-
tem of death registry which are more in consonance 
with the GBD project, most specifically the incorpora-
tion of a recent GBD approach to garbage code distribu-
tion. The GBD also is evolving in its methodologies, and 
future changes in the redistribution of garbage codes are 
anticipated.
A limitation of this study is the fact that deaths coded 
in E10-E14, when considered within the broader frame-
work of the multicausality of disease, are only part of 
the overall mortality that can be logically attributed to 
diabetes. Many deaths from complications which the 
epidemiologic literature suggests can be attributed to 
diabetes—heart disease, stroke, renal failure, and even 
cancer [32] and some infectious diseases such as tubercu-
losis—[33] will never formally be indicated in mortality 
registry systems as due to diabetes. Studies suggest that 
mortality attributable to diabetes could be from 50 % to 
as much as three times greater than that calculated using 
diabetes as the underlying cause of death [34–38]. Since 
we have only analyzed the underlying cause of death, 
without considering the remaining causes listed in part 
I of the death certificate, frequent direct causes such as 
myocardial infarction, stroke or pneumonia were not 
included in this report. Further, due to the process of 
coding, even if such direct causes of deaths were present 
on the death certificate, the diabetes ICD code chosen 
would most likely end in .9  (“without complications”), 
as no specific additional digit is available for the coding 
many of the important specific complications. Neverthe-
less, we believe that the ICD, inadequate as it is, still pro-
vides the basic information necessary to describe trends 
in diabetes mortality, the objective of our manuscript.
Another limitation is related to the methods used to 
assess completeness of death registration using indi-
rect demographic methods with some controversial 
assumptions like absence of migration, and constancy of 
incompleteness across all ages. These assumptions could 
potentially affect measures of completeness and the esti-
mates of mortality rates [39].
In conclusion, our data suggest that standardized pre-
mature mortality due to diabetes, based on death cer-
tificate coding, has declined in Brazil over the 15  years 
from 1996 to 2011. The rate appears to have stabilized in 
the later years of this series, suggesting that the effect of 
the increasing prevalence of diabetes now threatens to 
reverse this trend by outweighing the gains made through 
better patient care. These data suggest that for the decline 
to continue, solutions must be found not only to improve 
diabetes care but also to prevent the current epidemic 
increase in the incidence of diabetes.
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